How I Treat Elderly or Comorbid Patients with Chronic Lymphocytic Leukemia
Treatment of chronic lymphocytic leukemia (CLL) has recently undergone several major changes. Most importantly, large randomized trials (CLL-8 in first line and REACH in relapse) clearly demonstrated superiority of chemoimmunotherapy consisting of fludarabine, cyclophosphamide and rituximab (FCR) ov...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2010-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/53/4/0213/ |